Our previous studies showed that CD38 deficiency protected against cardiac hypertrophy and ischemia/reperfusion injury, alleviated vascular remodeling in hypertension, attenuated diabetic cardiopathy, and delayed D-galactose-induced cardiomyocyte senescence in mice [15,16,17,18]. Here, CD38 is linked to cardiac hypertrophy.